II-VI Incorporated develops, manufactures, and markets engineered materials, and optoelectronic components and devices worldwide. The company operates in three segments: II-VI Laser Solutions, II-VI Photonics, and II-VI Performance Products. The II-VI Laser Solutions segment offers optical and electro-optical components and materials primarily used in high-power CO2 lasers; fiber-delivered beam delivery systems, and processing tools and direct diode lasers for industrial lasers; direct diode laser modules, sub-systems, and systems; super-hard materials processing laser systems; and compound semiconductor epitaxial and gallium arsenide wafers. The II-VI Photonics segment provides crystal materials, optics, microchip lasers, and optoelectronic modules for use in optical communication networks and other consumer, life sciences, and commercial applications. It also offers pump lasers, optical isolators, and optical amplifiers and micro-optics for optical amplifiers for terrestrial and submarine applications within the optical communications market. The II-VI Performance Products segment provides infrared optical components and high-precision optical assemblies for military, medical, and commercial laser imaging applications; and silicon carbide engineered materials for thermoelectric devices and subsystems for silicon carbide applications. The company serves OEMs, laser end-users, system integrators of high-power lasers, manufacturers of equipment and devices for the industrial, optical communications, military, semiconductor, medical and life science markets, consumers, the U.S. government prime contractors, various U.S. government agencies, and thermoelectric integrators. It has strategic collaboration with Sumitomo Electric Device Innovations, Inc. to establish vertically integrated wafer fabrication platform. II-VI Incorporated was founded in 1971 and is headquartered in Saxonburg, Pennsylvania.
Industry, Sector and Symbol
Industry Optical instruments & lenses
Sub-IndustryElectrical Components & Equipment
SectorIndustrial Products
Phone724-352-4455
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.16 billion
Profitability
Miscellaneous
Employees11,443
Next Earnings Date5/7/2019 (Estimated)
OptionableOptionable
II-VI (NASDAQ:IIVI) Frequently Asked Questions
What is II-VI's stock symbol?
II-VI trades on the NASDAQ under the ticker symbol "IIVI."
How were II-VI's earnings last quarter?
II-VI, Inc. (NASDAQ:IIVI) released its quarterly earnings data on Thursday, January, 3rd. The scientific and technical instruments company reported $0.44 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.46 by $0.02. The scientific and technical instruments company earned $342.84 million during the quarter, compared to analyst estimates of $339.22 million. II-VI had a net margin of 8.81% and a return on equity of 10.93%. View II-VI's Earnings History.
When is II-VI's next earnings date?
What guidance has II-VI issued on next quarter's earnings?
II-VI issued an update on its third quarter earnings guidance on Thursday, January, 31st. The company provided EPS guidance of $0.60-0.69 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.66. The company issued revenue guidance of $335-343 million, compared to the consensus revenue estimate of $339.16 million.II-VI also updated its Q3 2019 guidance to $0.60-0.69 EPS.
What price target have analysts set for IIVI?
11 brokerages have issued 1-year price targets for II-VI's stock. Their forecasts range from $40.00 to $64.00. On average, they expect II-VI's share price to reach $50.30 in the next twelve months. This suggests a possible upside of 35.4% from the stock's current price. View Analyst Price Targets for II-VI.
What is the consensus analysts' recommendation for II-VI?
11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for II-VI in the last year. There are currently 1 sell rating, 2 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for II-VI.
Has II-VI been receiving favorable news coverage?
Media coverage about IIVI stock has trended somewhat negative on Tuesday, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. II-VI earned a news impact score of -1.4 on InfoTrie's scale. They also gave headlines about the scientific and technical instruments company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days.
Who are some of II-VI's key competitors?
What other stocks do shareholders of II-VI own?
Who are II-VI's key executives?
II-VI's management team includes the folowing people:
- Dr. Vincent D. Mattera Jr., Pres, CEO & Director (Age 63)
- Ms. Mary Jane Raymond, CFO, Treasurer & Assistant Sec. (Age 59)
- Mr. Gary Alan Kapusta, Chief Operating Officer (Age 59)
- Dr. Giovanni Barbarossa, CTO & Pres of Laser Solutions Segment (Age 59)
- Ms. Jo Anne Schwendinger, Chief Legal & Compliance Officer and Sec. (Age 64)
Who are II-VI's major shareholders?
II-VI's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Dimensional Fund Advisors LP (4.30%), Barrow Hanley Mewhinney & Strauss LLC (3.21%), Macquarie Group Ltd. (2.39%), Fort Pitt Capital Group LLC (1.78%), Robecosam AG (1.76%) and Northern Trust Corp (1.50%). Company insiders that own II-VI stock include David G Wagner, Francis J Kramer, Howard H Xia, Joseph J Corasanti, Marc Y E Pelaez, Mary Jane Raymond, Vincent D Mattera Jr and Wendy F Dicicco. View Institutional Ownership Trends for II-VI.
Which major investors are selling II-VI stock?
IIVI stock was sold by a variety of institutional investors in the last quarter, including Nomura Holdings Inc., Amundi Pioneer Asset Management Inc., Emerald Advisers LLC, Crestline Management LP, Royce & Associates LP, United Services Automobile Association, Barrow Hanley Mewhinney & Strauss LLC and Principal Financial Group Inc.. Company insiders that have sold II-VI company stock in the last year include David G Wagner, Francis J Kramer, Joseph J Corasanti, Marc Y E Pelaez, Mary Jane Raymond and Vincent D Mattera Jr. View Insider Buying and Selling for II-VI.
Which major investors are buying II-VI stock?
IIVI stock was purchased by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., DNB Asset Management AS, Millennium Management LLC, Macquarie Group Ltd., Norges Bank, Robecosam AG, D. E. Shaw & Co. Inc. and Whittier Trust Co.. View Insider Buying and Selling for II-VI.
How do I buy shares of II-VI?
Shares of IIVI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is II-VI's stock price today?
One share of IIVI stock can currently be purchased for approximately $37.14.
How big of a company is II-VI?
II-VI has a market capitalization of $2.35 billion and generates $1.16 billion in revenue each year. The scientific and technical instruments company earns $88 million in net income (profit) each year or $1.72 on an earnings per share basis. II-VI employs 11,443 workers across the globe.
What is II-VI's official website?
How can I contact II-VI?
II-VI's mailing address is 375 SAXONBURG BLVD, SAXONBURG PA, 16056. The scientific and technical instruments company can be reached via phone at 724-352-4455 or via email at [email protected]
MarketBeat Community Rating for II-VI (NASDAQ IIVI)
MarketBeat's community ratings are surveys of what our community members think about II-VI and other stocks. Vote "Outperform" if you believe IIVI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IIVI will underperform the S&P 500 over the long term. You may vote once every thirty days.
